FDA Approved: LATANOPROST — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for latanoprost from Rising Pharma Holdings, Inc., granting a new generic latanoprost product under ANDA 202442.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Latanoprost (Latanoprost)

Snippet

SUPPL AP for LATANOPROST (LATANOPROST)